Kenya's health ministry, through NASCOP, NSDCC, KRCS, county governments, partners and communities, is committed to ending ...
The plan underscores Kenya’s progressive approach to combination HIV prevention, offering a range of proven and emerging options including condoms, the dapivirine ring, long-acting injectable ...
Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
Swiss study shows 60% of migrant HIV diagnoses are made post-arrival, challenging assumptions about when infections actually ...
Bizcommunity.com on MSN
New hope for HIV prevention in South Africa with lenacapavir approval
The South African Health Products Regulatory Authority (SAHPRA) has announced the registration of lenacapavir, making South ...
AllAfrica on MSN
South Africa: Lenacapavir - a Game-Changer in South Africa's HIV Prevention Strategy
When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in January this year, we immediately set about finding solutions. Among the most pressing was to ...
The Citizen on MSN
Breakthrough HIV prevention jab given green light in S.Africa
The South African Health Products Regulatory Authority (SAHPRA) has registered the drug Lenacapavir, which the World Health ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...
There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...
SAHPRA has registered Lenacapavir, a new six-monthly PrEP injection to prevent HIV-1 in adults and adolescents over 35 kg.
Africanews on MSN
South Africa gives twice-yearly HIV prevention jab the green light
A vial of lenacapavir at the Desmond Tutu Health Foundation's research site, Cape Town, South Africa, 23 July 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results